<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-IND-C-SAATHII-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Contribute to the national goals of ending AIDS by 2030, and TB elimination by 2025 - India (01-Apr-2024-31-Mar-2027)</narrative>
    </title>
    <description type="1">
      <narrative>India, TB/HIV, Solidarity and Action Against The HIV Infection in India</narrative>
    </description>
    <description type="2">
      <narrative>Goals: The goal of the project is to contribute to the national goal of ending AIDS by 2030. The program will support NACO's expansion of its new model for a comprehensive continuum of care from prevention to treatment; To reduce morbidity and mortality due to TB and contribute to achieving National TB Program's goal of elimination by 2025. Objectives: Increase the proportion of prison inmates and those at OCS who know their HIV status from 56% to 100% in 10 states/UTs; Increase the proportion of other vulnerable populations (spouses and family members, and partners of PLHIV) who know their HIV status from 43% to 73% in 10 states/UTs; Increase the proportion of HIV-exposed infants who received the virological test within 6 months of birth from 92% to 100% in 10 states/Uts; Increase the proportion of PLHIV LFU to ART Center tracked back with definite outcome from 50% to 98% in 10 states/UTs; Increase the proportion of PLHIV due for VL test that have been tested for VL from 60% to 95%; Increase the pediatric TB case notification in nine states from 59219 (2022) to 74170 (2026-27); Increase the pediatric TB treatment success rate in nine states from 90% (2021) to 92% (2026-27); Increase the annual TB case notification by 4564 in 60 districts of 8 states through deployment of portable handheld X-ray device as part of TB case finding activities; Increase the annual TB case notification among the prisoners from 18 to 142 in 10 states and UTs by March 2027.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
    </participating-org>
    <other-identifier ref="IND-C-SAATHIIP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-04-01" />
    <activity-date type="2" iso-date="2024-04-01" />
    <activity-date type="3" iso-date="2027-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Gyongyver Jakab</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>gyongyver.jakab@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="IN" percentage="100">
      <narrative>India</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="42.4">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="36.36">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="21.24">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="a120a70d-52df-43de-97e1-765d63db4170" percentage="7.43">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; HIV prevention communication, information and demand creation for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="34.91">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="30.26">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="80d429dc-894d-4f0c-99cc-2403b8f1f5fe" percentage="4.48">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: HRH planning, management and governance including for community health workers (CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="1.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="14.64">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="6.45">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">4972634.54</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">9612656.99</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">6997048.43</value>
    </budget>
    <capital-spend percentage="1.66" />
    <transaction ref="c11f6eb1-a254-4c75-97ef-f5f7a919ad69">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-09" />
      <value currency="USD" value-date="2024-04-09">14521777.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d5ac54d-18db-485e-a101-077f72f3d6e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-11" />
      <value currency="USD" value-date="2024-04-11">1316722.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0e7f05b-03b6-4dd2-80d7-9af6b59df011">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-15" />
      <value currency="USD" value-date="2024-08-15">2304581.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="86ec5bc7-08bc-48b9-89a7-fc9a4b8db8c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-28" />
      <value currency="USD" value-date="2024-11-28">1593149.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="483fb4fe-c2ca-453f-a9f5-028432f8ca10">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-25" />
      <value currency="USD" value-date="2025-02-25">1061861.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="80ba09ec-62d1-4727-bf47-0b99bc043026">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-20" />
      <value currency="USD" value-date="2025-05-20">1693210.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f8fcd45-6096-4add-86d3-fd3c18feefe0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">159823.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3010cf69-f9cf-41dc-9c8c-2c04f9762cdd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">159823.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="44c096d3-b5e3-487d-ac81-fa934952e0d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">708779.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8286cac4-695a-48f1-b616-1be73ce76b35">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">8220.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="36b3d1d8-8cf6-48bf-aad4-0c58a485f33c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">7170887.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f3bb8e9d-0973-4a8e-ab91-1c764ad29b81">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">-5835255.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="34601102-ed87-46b4-a688-8584c5f09fc8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">2915239.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="baedcb77-0685-4027-a044-86aab1617657">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">8220.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d1500de-9281-4c29-9b34-4b0de9b12e3f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-10" />
      <value currency="USD" value-date="2026-03-10">914750.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3fefd0c-1a65-482a-8a0d-e23ada230d08">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-26" />
      <value currency="USD" value-date="2026-05-26">1543470.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="358e3a74-24c2-4f94-838f-4019af90a2b8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-10" />
      <value currency="USD" value-date="2026-08-10">-1789208.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c91a2df-ae54-49ee-867c-bc5da59d43d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-10" />
      <value currency="USD" value-date="2026-08-10">7354316.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4fc222c0-ce99-4663-a865-1f3530410df1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">1825900.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="41aaceb7-907f-41cd-8bb2-251e3faa6163">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">1987992.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="IND-C-SAATHIIP01-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">4972634.55</value>
      <description>
        <narrative>Expenditure reported by Solidarity and Action Against The HIV Infection in India for IND-C-SAATHIIP01, Apr 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/IND-C-SAATHII" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/IND/2023/Tuberculosis/en/IND-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - Tuberculosis - India - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1448-IND-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/IND/2023/HIV/en/IND-H_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - HIV - India - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1447-IND-H.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="2">
        <narrative>3 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="3">
        <narrative>4 - 1. Grant Funds may be used to pay for the services of an external auditor retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; 2. The Principal Recipient consents, to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2024-2025, 2025-2026 and 2026-2027 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing), and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and 3. Without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12066; Denominator: 301644; Percentage: 4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12066; Denominator: 301644; Percentage: 4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 289578; Denominator: 301644; Percentage: 96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 289578; Denominator: 301644; Percentage: 96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 301644.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 431036.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 418809.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 215518.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 215518.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 222106.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16982.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 205010.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 431692.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 473710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 237119.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16986.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 220043.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="58.63">
          <comment>
            <narrative>Numerator: 37333; Denominator: 63674.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 9551; Denominator: 15919.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 19102; Denominator: 31838.</narrative>
            </comment>
          </target>
          <actual value="89.07">
            <comment>
              <narrative>Numerator: 19771; Denominator: 22196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 9551; Denominator: 15919.</narrative>
            </comment>
          </target>
          <actual value="88.43">
            <comment>
              <narrative>Numerator: 9380; Denominator: 10607.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="90" />
          <actual value="96.02">
            <comment>
              <narrative>Numerator: 24736; Denominator: 25760.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="90" />
          <actual value="95.41">
            <comment>
              <narrative>Numerator: 11428; Denominator: 11978.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>VT Other-1-Percentage of HIV-exposed infants tested for HIV at 6 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>VT Other-1-Percentage of HIV-exposed infants tested for HIV at 6 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="92.03">
          <comment>
            <narrative>Numerator: 4598; Denominator: 4996.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="92" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92" />
          <actual value="85.16">
            <comment>
              <narrative>Numerator: 6682; Denominator: 7846.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92" />
          <actual value="92.36">
            <comment>
              <narrative>Numerator: 3314; Denominator: 3588.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="95" />
          <actual value="94.46">
            <comment>
              <narrative>Numerator: 5477; Denominator: 5798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="95" />
          <actual value="94.28">
            <comment>
              <narrative>Numerator: 2934; Denominator: 3112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="18" />
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="65" />
          <actual value="180" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="32" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="33" />
          <actual value="105" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="131" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="289" />
          <actual value="321" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="158" />
          <actual value="173" />
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="184" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="210" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="60.32">
          <comment>
            <narrative>Numerator: 441673; Denominator: 732255.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="75" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="75" />
          <actual value="95.32">
            <comment>
              <narrative>Numerator: 378528; Denominator: 397095.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="75" />
          <actual value="95.32">
            <comment>
              <narrative>Numerator: 378528; Denominator: 397095.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="85" />
          <actual value="86.52">
            <comment>
              <narrative>Numerator: 65861; Denominator: 76122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="85" />
          <actual value="86.52">
            <comment>
              <narrative>Numerator: 65861; Denominator: 76122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT Other-1 Number of pediatric patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB.</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>TBDT Other-1 Number of pediatric patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="55114" />
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="64756" />
          <actual value="58058" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="31449" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="33307" />
          <actual value="26194" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="36448" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="75860" />
          <actual value="65365" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="39412" />
          <actual value="30321" />
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="43709" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="43709" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT Other-2 Treatment success rate- all forms: Percentage of pediatric patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among pediatric TB patients notified during a specified period; *includes only those with new and relapse TB.</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TBDT Other-2 Treatment success rate- all forms: Percentage of pediatric patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among pediatric TB patients notified during a specified period; *includes only those with new and relapse TB.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="89.91">
          <comment>
            <narrative>Numerator: 42039; Denominator: 46759.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="90.8">
            <comment>
              <narrative>Numerator: 55394; Denominator: 61040.</narrative>
            </comment>
          </target>
          <actual value="95.11">
            <comment>
              <narrative>Numerator: 49665; Denominator: 52219.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="90.5">
            <comment>
              <narrative>Numerator: 27621; Denominator: 30520.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 27773; Denominator: 30520.</narrative>
            </comment>
          </target>
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 21371; Denominator: 22615.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 28776; Denominator: 31449.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="91.8">
            <comment>
              <narrative>Numerator: 59418; Denominator: 64756.</narrative>
            </comment>
          </target>
          <actual value="93.98">
            <comment>
              <narrative>Numerator: 50768; Denominator: 54021.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 30642; Denominator: 33307.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 23710; Denominator: 25305.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="92.5">
            <comment>
              <narrative>Numerator: 33714; Denominator: 36448.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="92.5">
            <comment>
              <narrative>Numerator: 36456; Denominator: 39412.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCS Other-1 Percentage of PLHIV on ART who are Lost to follow up (LFU)  tracked with definite outcome</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCS Other-1 Percentage of PLHIV on ART who are Lost to follow up (LFU)  tracked with definite outcome</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="50.15">
          <comment>
            <narrative>Numerator: 1699; Denominator: 3388.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="70" />
          <actual value="53.08">
            <comment>
              <narrative>Numerator: 28256; Denominator: 53237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="70" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="70" />
          <actual value="53.08">
            <comment>
              <narrative>Numerator: 28256; Denominator: 53237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="80" />
          <actual value="80.72">
            <comment>
              <narrative>Numerator: 51553; Denominator: 63868.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="80" />
          <actual value="80.72">
            <comment>
              <narrative>Numerator: 51553; Denominator: 63868.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>